Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC in Gastric Cancer with Positive Cytology
NCT01683864Phase 3Terminated
- Sponsor
- University Hospital Tübingen
- Start
- Sep 2012
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mitomycin c, cisplatin in gastric cancer (GC), sponsored by University Hospital Tübingen. Started Sep 2012; status: terminated.
02
Drugs
mitomycin ccisplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01683864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01683864.